Rapid Micro Biosystems (NASDAQ:RPID) CEO Robert Jr. Spignesi Sells 38,327 Shares of Stock

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) CEO Robert Jr. Spignesi sold 38,327 shares of the business’s stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $3.89, for a total value of $149,092.03. Following the transaction, the chief executive officer directly owned 1,187,770 shares in the company, valued at $4,620,425.30. This trade represents a 3.13% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Rapid Micro Biosystems Price Performance

RPID stock opened at $3.89 on Friday. The company has a debt-to-equity ratio of 0.42, a current ratio of 4.23 and a quick ratio of 2.95. The company has a market cap of $172.40 million, a P/E ratio of -3.85 and a beta of 1.38. The firm has a 50-day moving average of $3.67 and a 200 day moving average of $3.41. Rapid Micro Biosystems, Inc. has a 1 year low of $1.86 and a 1 year high of $4.94.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in RPID. Hudson Bay Capital Management LP purchased a new stake in shares of Rapid Micro Biosystems during the 3rd quarter worth about $38,000. Fifth Lane Capital LP purchased a new stake in Rapid Micro Biosystems in the 4th quarter valued at about $51,000. American Century Companies Inc. lifted its stake in Rapid Micro Biosystems by 46.1% during the second quarter. American Century Companies Inc. now owns 16,922 shares of the company’s stock worth $58,000 after purchasing an additional 5,341 shares in the last quarter. OMERS ADMINISTRATION Corp purchased a new stake in Rapid Micro Biosystems during the 4th quarter worth approximately $71,000. Finally, Nano Cap New Millennium Growth Fund L P purchased a new stake in Rapid Micro Biosystems during the 4th quarter worth about $72,000. 52.60% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of analysts recently commented on RPID shares. Weiss Ratings reiterated a “sell (d-)” rating on shares of Rapid Micro Biosystems in a research report on Thursday, January 22nd. Wall Street Zen raised shares of Rapid Micro Biosystems from a “sell” rating to a “hold” rating in a research note on Saturday, February 14th. One investment analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Rapid Micro Biosystems currently has a consensus rating of “Hold” and a consensus price target of $8.00.

About Rapid Micro Biosystems

Rapid Micro Biosystems (NASDAQ: RPID) develops and commercializes automated microbial detection and contamination control solutions for the life sciences industry. Its flagship offering, the Growth Direct® System, leverages digital imaging and proprietary growth indicator plates to identify and count microorganisms more rapidly than traditional culture-based methods. The company’s technology platform is designed to streamline quality control workflows in pharmaceutical, biotechnology and vaccine manufacturing settings, helping clients reduce release times and improve operational efficiency.

In addition to the Growth Direct® System, Rapid Micro Biosystems offers an integrated suite of software and consumables that support automated data capture, analysis and reporting.